HomeInsightsResults

Bharat Immunological & Biological Corporation Ltd Quarterly Result

Bharat Immunological & Biological Corporation Ltd Quarterly Result

stocks purchased

₹ 2.9 Cr

Volume Transacted

(Jan 6, 2025)

stocks purchased

944.6 K

Stocks Traded

(Jan 6, 2025)

Last Updated on: Jan 07, 2025

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

Net Profit

₹ -4.92

Last updated on: Jan 07, 2025

Key Highlights

  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ 0.16 crore as compare to the Jun '23 revenue of ₹ 0.1 crore. This represent the growth of 59.999996%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ -4.52 crore as compare to the Jun '23 ebitda of ₹ -4.21 crore. This represent the growth of 7.363419%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd for the Sep '23 is ₹ -4.92 crore as compare to the Jun '23 net profit of ₹ -4.59 crore. This represent the growth of 7.1895404%.

Results Analysis

Market Price of Bharat Immunological & Biological Corporation Ltd

1M

1Y

3Y

5Y

Monitoring Bharat Immunological & Biological Corporation Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Jan 202530.32
03 Jan 202525.27
02 Jan 202524.1
01 Jan 202524.45
31 Dec 202423.74
30 Dec 202423.85
27 Dec 202424.5
26 Dec 202423.45
24 Dec 202423.21
23 Dec 202423.53

Historical Revenue of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical EBITDA of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Net Profit of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

News

Bharat Immunological & Biolog.Corp. to conduct board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

20 Oct 2023 11:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Bharat Immunological & Biological Corporation Ltd

What key financial metrics are included in Bharat Immunological & Biological Corporation Ltd's quarterly results?

Key financial metrics in Bharat Immunological & Biological Corporation Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Bharat Immunological & Biological Corporation Ltd announce its quarterly results?

Bharat Immunological & Biological Corporation Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Bharat Immunological & Biological Corporation Ltd's quarterly performance impact its stock price?

Bharat Immunological & Biological Corporation Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Bharat Immunological & Biological Corporation Ltd's quarterly results on dividends?

The impact of Bharat Immunological & Biological Corporation Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Bharat Immunological & Biological Corporation Ltd's quarterly results?

Yes, Bharat Immunological & Biological Corporation Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions